Meningitis News and Research

Latest Meningitis News and Research

GAVI to purchase $1 billion in childhood vaccines for distribution in 37 of the poorest nations

The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports.

28 Sep 2011

Researchers discover how a novel type of antibody works against pneumococcal bacteria

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how a novel type of antibody works against pneumococcal bacteria.

23 Sep 2011

ASU scientists receive USDA grants to combat food-related illness

Roughly 1 in six Americans are sickened every year by food-borne ailments, according to the Centers for Disease Control and Prevention. The effects of these illnesses range from acutely unpleasant to lethal, and the problem may be getting worse, as our food supply becomes more global, with an increasing number of antibiotic-resistant pathogens.

21 Sep 2011

Supplement in USA Today highlights global NTD eradication efforts

This supplement (.pdf) by Mediaplanet, distributed in the September 15 issue of USA Today in select cities nationwide, examines the latest programs dedicated to eradicating neglected tropical diseases (NTDs) worldwide.

17 Sep 2011

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1 clinical study of VT-1161, an oral, potent and selective antifungal agent. VT-1161 is a novel small molecule discovered by Viamet Pharmaceuticals using its proprietary Metallophile Technology.

14 Sep 2011

Eleven UvA researchers named as recipients of ERC Starting Grants

Eleven researchers from the University of Amsterdam (UvA) have been named as recipients of Starting Independent Researcher Grants from the European Research Council.

31 Aug 2011

High risk of serious complications or death in children with SP-HUS

Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.

30 Aug 2011

IOM report: Few health problems are clearly associated with vaccines

An analysis of more than 1,000 research articles concluded that few health problems are caused by or clearly associated with vaccines.

26 Aug 2011

IMMY, University of Nevada receive FDA clearance for CrAg Lateral Flow Assay

The Food and Drug Administration has cleared a new diagnostic test that will help save the lives of hundreds of thousands of AIDS patients stricken with cryptococcosis, a fungal meningitis.

25 Aug 2011

Emory team identifies conditions that make memory T cells slip away during chronic infections

After recovering from the flu or another acute infection, your immune system is ready to react quickly if you run into the same virus again. White blood cells called memory T cells develop during the infection and help the immune system remember the virus and attack it if it comes back.

19 Aug 2011

Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has completed patient recruitment in a clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.

17 Aug 2011

Sinovac second quarter sales increase 52.5% to $15.7 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2011.

12 Aug 2011

NanoLogix BNP and BNF Quick Test kits detect, identify Group B Strep in four to six hours

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today that the American Journal of Perinatology has published a peer-reviewed paper from the University of Texas Health Science Center - Houston confirming NanoLogix BioNanoPore (BNP) and BioNanoFilter (BNF) Quick Test technology detect and identify Group B Strep in four to six hours.

8 Aug 2011

Akonni to develop closed amplicon RT-PCR microarray for virus detection in CSF

Akonni Biosystems, a molecular diagnostics company that develops novel nucleic acid extraction and microarray-based testing systems designed to rapidly and economically analyze biological samples, today announced receipt of a $300K grant from the National Institutes of Health.

5 Aug 2011

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist Pharmaceuticals, Inc. today announced the initiation of a pivotal Phase 3 trial of CXA-201 in patients with complicated urinary tract infections.

1 Aug 2011

FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults

Pfizer Inc today announced that the U.S. Food and Drug Administration (FDA) has issued a 90-day extension to the action date for the Company's supplemental Biologics License Application (sBLA) for use of Prevnar 13, in adults aged 50 and older.

30 Jul 2011

NIH selects Viamet's novel antifungal compound for inclusion in the TRND program

Viamet Pharmaceuticals, Inc. announced today that one of its novel antifungal compounds has been selected for inclusion in the National Institutes of Health's (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program.

29 Jul 2011

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Baxter International Inc. announced today that the U.S. Food and Drug Administration has approved the subcutaneous administration of GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] for patients with primary immunodeficiency.

From Baxter International Inc. 25 Jul 2011

Financial Times examines product development partnerships developing drugs for neglected diseases

The Financial Times examines the rise of product development partnerships (PDPs), which are "non-governmental organizations that generate their own funding and build partnerships with universities, businesses, government and patients in low-income countries to develop new drugs, vaccines, prevention techniques and diagnostics for diseases such as tuberculosis, HIV, malaria, cholera and meningitis."

22 Jul 2011

NPR: Vaccine cost-benefit analysis complicates guidelines

The group that advises the U.S. government on vaccination thinks some new vaccines may not be worth the cost. In 2009, the Advisory Committee on Immunization Practices, or ACIP, decided it's not cost effective to routinely vaccinate boys for human papillomavirus, though they do recommend the vaccine for girls.

22 Jul 2011

Meningitis News and Research

Latest Meningitis News and Research

GAVI to purchase $1 billion in childhood vaccines for distribution in 37 of the poorest nations

Researchers discover how a novel type of antibody works against pneumococcal bacteria

ASU scientists receive USDA grants to combat food-related illness

Supplement in USA Today highlights global NTD eradication efforts

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Eleven UvA researchers named as recipients of ERC Starting Grants

High risk of serious complications or death in children with SP-HUS

IOM report: Few health problems are clearly associated with vaccines

IMMY, University of Nevada receive FDA clearance for CrAg Lateral Flow Assay

Emory team identifies conditions that make memory T cells slip away during chronic infections

Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial

Sinovac second quarter sales increase 52.5% to $15.7 million

NanoLogix BNP and BNF Quick Test kits detect, identify Group B Strep in four to six hours

Akonni to develop closed amplicon RT-PCR microarray for virus detection in CSF

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults

NIH selects Viamet's novel antifungal compound for inclusion in the TRND program

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Financial Times examines product development partnerships developing drugs for neglected diseases

NPR: Vaccine cost-benefit analysis complicates guidelines

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Meningitis News and Research

Latest Meningitis News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in